The key to this process was a unique ‘giant’ virus known as Mimivirus. This research was co-authored by Ms. Kanako Morioka ...

In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

In the years before the introduction of respiratory syncytial virus (RSV) vaccines, the virus was linked with substantial ...

The mortality risk within 90 days of hospitalization is similar and higher among older adults hospitalized with respiratory syncytial virus (RSV) vs influenza A and those hospitalized with RSV vs ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance ...

RSV vaccines effective, but more people need to get them Date: October 28, 2024 Source: University of Rochester Medical Center Summary: Doctors detail what we learned after the first season ...

The North Bay Parry Sound District Health Unit announced the availability of a new preventive medication for Respiratory Syncytial Virus for newborns and eligible infants up to 24 months of age. The ...

Public health experts are warning that the rising rates of RSV in the Southern U.S. could be a sign we need to prepare here in Southern California At one hospital in Texas, doctors are sounding the ...